Login / Signup

Reply to Kiran Javaid and Cassidy Andruszka: Early disease intervention with guselkumab in psoriasis leads to a higher rate of stable complete skin clearance ('clinical super response'): Week 28 results from the ongoing phase IIIb randomized, double-blind, parallel-group, GUIDE study: An analysis with considerations for future studies.

Knut Schäkel
Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Keyphrases
  • double blind
  • placebo controlled
  • phase iii
  • clinical trial
  • randomized controlled trial
  • phase ii
  • open label
  • study protocol
  • current status
  • soft tissue